NCT05986331 - Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma | Biotech Hunter

Enrollment

366

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions

Melanoma (Skin)

Interventions

DRUG

BCD-201

up to 8 treatment cycles

DRUG

Keytruda

up to 8 treatment cycles

Trial Locations (3)

"Budgetary healthcare institution of the Omsk region Clinical oncological dispensary", Omsk

"Saint Petersburg Clinical Research and Practice Center for Specialized Medical Care (Oncology)", Saint Petersburg

"Federal State Budgetary Educational Institution of Higher Education Saint Petersburg State University", Saint Petersburg